Brief: U.S. appeals court voids $340 mln antitrust verdict against Becton Dickinson

Retractable Technologies

02/12/2016 16:58

Dec 2 (Reuters) - Becton Dickinson And Co  BDX.N  
    * U.S. appeals court overturns retractable technologies' 
$340 million verdict against becton dickinson in antitrust case 
over syringes--court ruling 
    * 5th u.s. circuit court of appeals calls the claim that 
becton tried to monopolize u.s. safety syringe market 'infirm as 
a matter of law' 
    * Appeals court says "patent infringement, which operates to 
increase competition, is not anticompetitive conduct" 
    * Appeals court says allegation that becton tainted market 
for retractable syringes while quietly plotting to sell its own 
"unsupported and incoherent" 
    * Appeals court upholds jury finding that becton is liable 
for false advertising, but orders that damages be recalculated 
 
Further company coverage:  BDX.N   RVP.A